everolimus
NDC 82293-030, everolimus, tablet, from Novugen Pharma (USA) LLC..
- Product NDC
- 82293-030
- Status
- Listed
- Labeler
- Novugen Pharma (USA) LLC.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA219955
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82293-030 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- EVEROLIMUS2.5 mg/1
Pharmacologic classes
Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Decreased Immunologic Activity [PE]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]; mTOR Inhibitor Immunosuppressant [EPC]; mTOR Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82293-030-10 | 82293003010 | 28 TABLET in 1 BOTTLE (82293-030-10) |
| 82293-030-21 | 82293003021 | 4 BLISTER PACK in 1 CARTON (82293-030-21) / 7 TABLET in 1 BLISTER PACK (82293-030-20) |
| 82293-030-31 | 82293003031 | 1 POUCH in 1 CARTON (82293-030-31) / 3 BLISTER PACK in 1 POUCH / 10 TABLET in 1 BLISTER PACK (82293-030-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/67e62e26-448d-46ec-b5a1-00dc1b5e26c6
Use it
Look up 82293-030 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82293-030 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82293-030. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.